Takeda has added 340B contract pharmacy restrictions to blood cancer treatment drug Mimrylo.

Takeda Adds Blood Cancer Drug to CP Restrictions Policy

September 11, 2026 Shannon Young, Managing Editor 340B Report Views

A Japanese pharmaceutical giant this week announced that it has added a blood cancer treatment to its list of drugs [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!